Hhr Asset Management, LLC Bluebird Bio, Inc. Transaction History

Hhr Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $138,194 - $282,303	-8,330 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $79,200 - $109,209	-2,880 Reduced 25.69%	8,330 $360,000
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $22,041 - $28,000	-640 Reduced 5.4%	11,210 $604,000
Q2 2020 Aug 07, 2020	SELL	$27.12 - $45.97 $53,155 - $90,101	-1,960 Reduced 14.19%	11,850 $723,000
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $64,804 - $85,104	-1,380 Reduced 9.08%	13,810 $1.21 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $1.15 Million - $1.6 Million	15,190 New	15,190 $1.93 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhr Asset Management, LLC with notifications on news.